CEL-SCI Corporation (NYSE AMEX: CVM) announced that its collaborators at the University of Hawaii reported on data at the annual American Society for Microbiology in Philadelphia, PA. This data demonstrates that vaccines utilizing its L.E.A.P.S.

read more

Deceases & treatment

• Specific immunotherapy (xenovaccinotherapy) for cancer
  • Melanoma
  • Kidney cancer
  • Colorectal cancer
  • Gastric cancer
  • Lung cancer
  • Prostate cancer
  • Astrocytoma
• T-cell vaccination (autovaccinotherapy) for autoimmune diseases
  • Multiple sclerosis
  • Rheumatoid arthritis
• Regenarative therapy
• Clinical application of stem celltransplantation
• Cell transplantation (CT) in treating severe neurological disorders (general information)
  • Spinal cord injury
  • Craniocerebral (brain) injury (coma)
  • Craniocerebral (brain) injury (long-term consequences)
  • Brain stroke
  • Cerebral palsy
  • 100 point scale for assessing neurological status of a cerebral palsy patient
• Hepatic diseases
• Osteomielitis
• Arthrosis

Site search